Celldex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.About CLDX
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.
CEOAnthony S. Marucci
CEOAnthony S. Marucci
Employees186
Employees186
HeadquartersHampton, New Jersey
HeadquartersHampton, New Jersey
Founded1983
Founded1983
Employees186
Employees186
CLDX Key Statistics
Market cap1.72B
Market cap1.72B
Price-Earnings ratio-8.13
Price-Earnings ratio-8.13
Dividend yield—
Dividend yield—
Average volume1.35M
Average volume1.35M
High today$26.33
High today$26.33
Low today$24.83
Low today$24.83
Open price$24.85
Open price$24.85
Volume1.39M
Volume1.39M
52 Week high$47.00
52 Week high$47.00
52 Week low$14.40
52 Week low$14.40
CLDX News
TipRanks 1d
Celldex’s barzo shows strong efficacy in CSU patients, says H.C. WainwrightCelldex (CLDX), at EADV 2025, disclosed new data from its Phase 2 study assessing barzolvolimab in CSU, showing that barzo has rapid efficacy in Chronic Spontan...
Simply Wall St 4d
Assessing Celldex Therapeutics's Valuation After Encouraging Phase 2 Barzolvolimab Results and Renewed Pipeline OptimismAdvertisement Price-to-Book of 2.5x: Is it justified? Celldex Therapeutics (CLDX) has attracted attention recently after announcing encouraging results from i...
Analyst ratings
86%
of 14 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.